| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/31/2007 | US20070122409 Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors |
| 05/31/2007 | US20070122405 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 05/31/2007 | US20070122403 Molecules with extended half-lives, compositions and uses thereof |
| 05/31/2007 | US20070122401 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 05/31/2007 | US20070122394 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/31/2007 | US20070122380 Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use |
| 05/31/2007 | US20070122379 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/31/2007 | US20070122354 possess superior aerosol properties, even in the absence of stabilizing carriers or excipients; inhalants; when administered to the deep lung, are useful for treating allergic diseases, such as asthma, atopy, and atopic dermatitis |
| 05/31/2007 | DE102005057643A1 Bacterial vaccine that allows differentiation between infected and vaccinated animals, particularly pigs, comprises knock-out mutations in at least three genes, one encoding an immunogenic protein that serves as marker |
| 05/31/2007 | CA2634187A1 Chimeric keratin-binding effector proteins |
| 05/31/2007 | CA2631443A1 Potent compstatin analogs |
| 05/31/2007 | CA2631013A1 Activin-actriia antagonists and uses for promoting bone growth |
| 05/31/2007 | CA2630929A1 Chimeric, hybrid and tandem polypeptides of meningococcal nmb1870 |
| 05/31/2007 | CA2630668A1 Intraocular pressure-regulated early genes and uses thereof |
| 05/31/2007 | CA2630652A1 Bioassays |
| 05/31/2007 | CA2630629A1 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 05/31/2007 | CA2630495A1 Neuropeptides for the culture of aquatic organisms |
| 05/31/2007 | CA2630283A1 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
| 05/31/2007 | CA2628725A1 Production of glycoproteins with reduced o-glycosylation |
| 05/31/2007 | CA2628530A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | CA2628342A1 Production and use of highly functional, highly branched or hyperbranched polylysines |
| 05/31/2007 | CA2627446A1 Compositions and methods of producing hybrid antigen binding molecules and uses thereof |
| 05/31/2007 | CA2621705A1 Erythropoietin polypeptides and uses thereof |
| 05/30/2007 | EP1790730A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790729A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790727A2 Proteins and nucleic acids encoding same |
| 05/30/2007 | EP1790726A2 Modified and stabilized GDF propeptides and uses thereof |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790724A1 Knockout nonhuman animal |
| 05/30/2007 | EP1790717A2 Compositions and methods for the identification of lung tumor cells |
| 05/30/2007 | EP1790716A1 Uses of the FcRn receptor |
| 05/30/2007 | EP1790662A1 Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer |
| 05/30/2007 | EP1790661A2 A highly efficient secretory signal peptide and a protein expression system using the peptide thereof |
| 05/30/2007 | EP1790660A2 Heterologous expression of neisserial proteins |
| 05/30/2007 | EP1790659A2 Polypeptides of pseudomonas aeruginosa |
| 05/30/2007 | EP1790658A2 Anti-viral vectors |
| 05/30/2007 | EP1790657A1 pH-switchable transmembrane peptides as stimulators of membrane fusion |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1790654A1 Peptide capable of binding to insulin-binding protein and adsorbent |
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1789799A2 Method of screening by using conformation sensitive peptides |
| 05/30/2007 | EP1789590A2 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof |
| 05/30/2007 | EP1789583A1 Methods for identifying a patient as a candidate for treatment with a long acting beta agonist and for predicting a patient's response to long acting beta 2 agonist therapy by analysing polymorphs ims in the beta 2 -adrenergic receptor gene |
| 05/30/2007 | EP1789566A1 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle |
| 05/30/2007 | EP1789562A2 Disarmed agrobacterium strains, ri-plasmids, and methods of transformation based thereon |
| 05/30/2007 | EP1789555A1 Novel regulation protein |
| 05/30/2007 | EP1789554A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 05/30/2007 | EP1789532A1 Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens |
| 05/30/2007 | EP1789452A2 Relaxin-chimeric polypeptides and their preparation and use |
| 05/30/2007 | EP1789449A1 Anti-glycated cd59 antibodies and uses thereof |
| 05/30/2007 | EP1789447A2 Method of delivering rna interference and uses thereof |
| 05/30/2007 | EP1789445A1 Method for removing fibronectin from plasma fractions |
| 05/30/2007 | EP1789444A1 Production of a von willebrand factor preparation using hydroxylapatite |
| 05/30/2007 | EP1789443A1 Muteins of fibroblast growth factor 21 |
| 05/30/2007 | EP1789442A2 Muteins of fibroblast growth factor 21 |
| 05/30/2007 | EP1789440A2 Pancreatic polypeptide family motifs and polypeptides comprising the same |
| 05/30/2007 | EP1789439A1 A purified arabinogalactan-protein (agp) composition |
| 05/30/2007 | EP1789438A2 Recombinant mva viruses expressing glade a/g, clade b, and clade c modified hiv, gag and pol genes |
| 05/30/2007 | EP1789437A1 Npc1l1 and npc1l1 inhibitors and methods of use thereof |
| 05/30/2007 | EP1789435A1 A method for production of mature natural killer cell |
| 05/30/2007 | EP1789093A2 Antibody vaccine conjugates and uses therefor |
| 05/30/2007 | EP1789089A2 Compositions and treatments using ex vivo activated cells for myelosuppressed patients |
| 05/30/2007 | EP1789085A2 Change of the load state of mhc molecules |
| 05/30/2007 | EP1789072A2 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 05/30/2007 | EP1601697B1 Antibody purification by Protein A and ion exchange chromatography |
| 05/30/2007 | EP1578948A4 Flj10607 as modifier of the axin pathway and methods of use |
| 05/30/2007 | EP1578921A4 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 05/30/2007 | EP1575967A4 Process for the extraction and isolation of insulin from recombinant sources |
| 05/30/2007 | EP1496925A4 Use of interleukin-24 to treat ovarian cancer |
| 05/30/2007 | EP1496924A4 Treatment of gastroparesis |
| 05/30/2007 | EP1492878B1 Process for the preparation of a desired erythropoietin glyco-isoform profile |
| 05/30/2007 | EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1070758B1 Human stanniocalcin and uses thereof to inhibit adipogenesis |
| 05/30/2007 | EP1019010B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 05/30/2007 | EP0975754B1 Osteoprotegerin binding proteins and receptors |
| 05/30/2007 | EP0904367B1 Scf analog compositions and methods |
| 05/30/2007 | EP0729975B9 Ecdn protein and dna coding for the same |
| 05/30/2007 | EP0726954B2 Cytokine antagonists |
| 05/30/2007 | CN1973044A Methods and materials for improving plant drought tolerance |
| 05/30/2007 | CN1973041A Therapeutic molecules and methods for generating and/or selecting same |
| 05/30/2007 | CN1973039A Stabilized proline transporter |
| 05/30/2007 | CN1973038A HCV RNA having novel sequence |
| 05/30/2007 | CN1973037A Process for producing dipeptides or dipeptide derivatives |
| 05/30/2007 | CN1972961A Isolation of plasma or serum proteins |
| 05/30/2007 | CN1972960A Processes for preparing eptifibatide |
| 05/30/2007 | CN1972959A Metastin derivatives and use thereof |
| 05/30/2007 | CN1972958A Method of using adenoviral vectors to induce an immune response |
| 05/30/2007 | CN1972710A Methods and compositions comprising bacteriophage nanoparticles |
| 05/30/2007 | CN1970773A Novel recombinant plasmid for expression of blood coagulation factor 8 in mammal cell |
| 05/30/2007 | CN1970767A Plant-related gene from paddy and its coded protein and application thereof |
| 05/30/2007 | CN1970766A Paraquat resistance gene and a vascular tissue- and trichome-specific promoter |
| 05/30/2007 | CN1970765A High-molecular wheat glutelin subunit gene, nucleic acid sequence of promoter thereof, and application thereof |
| 05/30/2007 | CN1970763A Shortened anti-oncogene p53 capable of increasing sensitivity of human lung cancer cell to antineoplastics |
| 05/30/2007 | CN1970574A Double function infusion protein for thrombolysis and anticoagulation , its preparation method and uses |
| 05/30/2007 | CN1970572A Interferon alpha mutant and its polyethylene glycol derivative |
| 05/30/2007 | CN1970571A G-csf analog compositions and methods |
| 05/30/2007 | CN1970570A Yeast engineered bacteria for expressing recombinant prawn protein Pen9 and its preparation method and uses |
| 05/30/2007 | CN1970569A Rice leaf curl-outward gene and its uses |